Dr. Ashwantha Enjapoori earned his Ph.D. from Deakin University, Australia, in 2014. His doctoral research focused on investigating the composition of monotreme (platypus and echidna) milk proteins, microRNAs, and the endocrine regulation of milk protein genes.
From 2015 to 2018, Dr. Enjapoori worked as a postdoctoral fellow at Deakin University, where he conducted advanced research on bovine and human beta-caseins. His work included studying the release of bioactive beta-casomorphin peptides through mass spectrometry-based peptidomics and proteomics. Additionally, he examined the relationship between bovine beta-casein proteins (A1 and A2) consumption and diabetes incidence using a mouse model.
In mid-2018, Dr. Enjapoori joined Noumi Limited (formerly known as Freedom Foods Group Limited) in Shepparton, Australia, as a Senior Protein Analyst. During his tenure, he established a state-of-the-art mass spectrometry-based proteomics laboratory to advance analytical research on bovine milk proteins such as lactoferrin, beta-caseins (A1 and A2), whey proteins, and plant-based milk. With extensive research over many years, he developed sophisticated analytical tools using the ÄKTA pure fast protein liquid chromatography system and mass spectrometry to assess the purity and absolute quantification of bovine lactoferrin, from raw materials to finished products. These robust methods ensured consistent product quality, enabling the clearance of lactoferrin and UHT milk products for both domestic and international markets.
Through these initiatives, Dr. Enjapoori gained invaluable expertise in milk research, the dairy industry, and the industrial production of bovine milk proteins, including lactoferrin, whey proteins, and micellar casein concentrate (MCC).
